Edition:
United Kingdom

People: Achillion Pharmaceuticals Inc (ACHN.OQ)

ACHN.OQ on NASDAQ Stock Exchange Global Select Market

4.77USD
16 Aug 2019
Change (% chg)

$0.05 (+1.06%)
Prev Close
$4.72
Open
$4.75
Day's High
$4.84
Day's Low
$4.72
Volume
318,225
Avg. Vol
422,572
52-wk High
$5.02
52-wk Low
$1.29

Manning, Martha 

Ms. Martha E. Manning Esq. is an Executive Vice President, General Counsel, Corporate Secretary of the Company. Ms. Manning has served as our Executive Vice President, General Counsel and Corporate Secretary since February 2016. Prior to joining Achillion in February 2016, Ms. Manning was General Counsel of iCeutica Inc., a drug development company from 2013 to 2016. She served as Chief Legal Officer of OraPharma, Inc., a pharmaceutical company, from 2011 to 2012 when the company was acquired by Valeant Pharmaceuticals, Inc. She joined OraPharma from Sandoz Inc., the generic pharmaceutical division of Novartis AG, where she served as Vice President and General Counsel from 2008 to 2011. Prior to Sandoz, she served as Senior Vice President, General Counsel and Secretary for Adolor Corporation, a publicly traded biopharmaceutical company from 2002 to 2008. Ms. Manning began her legal career with the law firm of Morgan, Lewis & Bockius. She received her J.D. from the University of Pennsylvania School of Law and her Bachelor of Business Administration from the University of Massachusetts.

Basic Compensation

Total Annual Compensation, USD 429,213
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 439,465
Fiscal Year Total, USD 868,678

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Nicole Vitullo

125,600

Joseph Truitt

3,275,990

Brian Di Donato

--

Paul Firuta

1,098,700

Martha Manning

868,678

Anthony Gibney

1,064,960
As Of  31 Dec 2018